Pharmacy Compounding Disclaimer May Be Alternative To FDAMA, Court Says
Disclaimers on compounded drugs may be a viable alternative to the speech restrictions called for under the FDA Modernization Act, a federal appeals court decision suggests.
More from Archive
More from Pink Sheet
• By
Brazil plans to clarify its medicine pricing framework, for example by outlining the procedures for setting medicine prices and bring it up to date with recent developments in the sector.
• By
England’s health technology assessment institute explains how its sandbox environment is helping to test new evaluation methods for drugs or indications with which it does not have experience, such as metabolic dysfunction-associated steatohepatitis.
• By
The European Medicines Agency, like its counterpart in the US, is increasingly focusing on the use of alternatives to animal testing.